Acute Kidney Injury Clinical Trials in Philadelphia, Pennsylvania

4 studies are recruiting for acute kidney injury in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

    This study will enroll adults aged 18 to 80 years diagnosed with sepsis due to a suspected or confirmed bacterial infection, within 7 days of being admitted to the hospital, and who have also developed acute kidney injury within 72 hours of the onset of sepsis. Eligible participants will be randoml…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Research Site, Philadelphia, Pennsylvania
    Locations
    74 in total
    Run by
    AstraZeneca

    See if you can join NCT07215702 on ClinicalTrials.gov

  2. CTSN Embolic Protection Trial

    This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

    Stage
    Not phased
    Ages
    60 and older
    Site
    Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
    Locations
    28 in total
    Run by
    Icahn School of Medicine at Mount Sinai

    See if you can join NCT06027788 on ClinicalTrials.gov

  3. QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

    QUELIMMUNE is FDA-approved under an HDE for the treatment of pediatric patients (weight ≥10kg and age ≤22 years) with AKI due to sepsis or a septic condition on antibiotic therapy and requiring RRT. The purpose of this surveillance registry is to prospectively collect safety data among all patients…

    Stage
    Not phased
    Ages
    Up to 22
    Site
    Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    Locations
    15 in total
    Run by
    SeaStar Medical

    See if you can join NCT06517810 on ClinicalTrials.gov

  4. A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients

    Hospitalized patients with suspected or confirmed infection are commonly treated with vancomycin (VN) in combination with either piperacillin-tazobactam (PT) or cefepime (CP). Although these regimens have similar effectiveness, recent observational evidence suggests they may differ in terms of the …

    Stage
    Phase 4
    Ages
    18 and older
    Site
    University of Pennsylvania Health System, Philadelphia, Pennsylvania
    Run by
    University of Pennsylvania

    See if you can join NCT06954129 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.